Publications by authors named "Neil Collinson"

Claim this Profile
O
Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY).
Arantxa Horga, Rebecca Saenz, Gürdal Yilmaz, Abraham Simón-Campos, Keith Pietropaolo, Neil Collinson

Future Virol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study).
Marta Boffito, Eamon Dolan, Karishma Singh, William Holmes, Steffen Wildum, Neil Collinson

Microbiol Spectr· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.
Deepali Kumar, Michael G Ison, Jean-Paul Mira, Tobias Welte, Jick Hwan Ha, Neil Collinson

Lancet Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
Leo Y Lee, Jie Zhou, Paulina Koszalka, Rebecca Frise, Rubaiyea Farrukee, Neil Collinson

PLoS Pathog· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2).
Jeffrey Baker, Stanley L Block, Balpreet Matharu, Laura Burleigh Macutkiewicz, Steffen Wildum, Neil Collinson

Pediatr Infect Dis J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission.
Leo Yi Yang Lee, Jie Zhou, Rebecca Frise, Daniel H Goldhill, Paulina Koszalka, Neil Collinson

PLoS Pathog· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.
John H Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer, Neil Collinson

Arthritis Rheumatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data.
Sara Gale, Huong Trinh, Katie Tuckwell, Neil Collinson, John H Stone

Rheumatol Ther· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
Vibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson

Arthritis Res Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK.
Sara Gale, Jessica C Wilson, Jenny Chia, Huong Trinh, Katie Tuckwell, Neil Collinson

Rheumatol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Tocilizumab in Giant-Cell Arteritis.
John H Stone, Micki Klearman, Neil Collinson

N Engl J Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Tocilizumab in Giant-Cell Arteritis.
John H Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer, Neil Collinson

N Engl J Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
Jessica C Wilson, Khaled Sarsour, Neil Collinson, Katie Tuckwell, David Musselman

Semin Arthritis Rheum· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Jessica C Wilson, Khaled Sarsour, Neil Collinson, Katie Tuckwell, David Musselman

Semin Arthritis Rheum· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.
Katie Tuckwell, Neil Collinson, Sophie Dimonaco, Micki Klearman, Daniel Blockmans

Semin Arthritis Rheum· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis.
Michael S Broder, Khaled Sarsour, Eunice Chang, Neil Collinson, Katie Tuckwell

Semin Arthritis Rheum· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and implementation of a double-blind corticosteroid-tapering regimen for a clinical trial.
Neil Collinson, Katie Tuckwell, Frank Habeck, Monique Chapman, Micki Klearman

Int J Rheumatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
Hans Petri, Alan Nevitt, Khaled Sarsour, Pavel Napalkov, Neil Collinson

Arthritis Care Res (Hoboken)· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients.
Ronald F van Vollenhoven, Paul Emery, Clifton O Bingham, Edward C Keystone, Roy M Fleischmann, Neil Collinson

Ann Rheum Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptor.
Gregori J Morriello, Gary Chicchi, Tricia Johnson, Sander G Mills, Julie Demartino, Neil Collinson

Bioorg Med Chem Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR).
Andrea Rubbert-Roth, Paul P Tak, Cristiano Zerbini, Jean-Luc Tremblay, Luis Carreño, Neil Collinson

Rheumatology (Oxford)· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists.
Gregori J Morriello, Sander G Mills, Tricia Johnson, Mikhail Reibarkh, Gary Chicchi, Neil Collinson

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists.
Gregori J Morriello, Robert J Devita, Sander G Mills, Jonathan R Young, Peter Lin, Neil Collinson

Bioorg Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate.
Victor Y Cheng, Loren J Martin, Erin M Elliott, John H Kim, Howard T J Mount, Neil Collinson

J Neurosci· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors.
John R Atack, Peter H Hutson, Neil Collinson, George Marshall, Graham Bentley

Br J Pharmacol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis